Pinellas Cancer Center Joins The Oncology Institute of Hope and Innovation

ST. PETERSBURG, Fla.--()--The Oncology Institute of Hope and Innovation (TOI) announced the acquisition of Pinellas Cancer Center, operated by Dr. Anil Raiker, marking TOI’s entry into the Florida market. TOI is a multi-state cancer care practice dedicated to healing and empowering patients through compassion, innovation, and state-of-the-art medical care. TOI is the largest value-based oncology practice in the U.S., taking accountability for both the quality outcomes as well as the medical costs associated with a population of more than 1 million patients.

Founded in 2007, The Oncology Institute currently operates 40+ locations across 4 states and is adding additional locations and oncologists in the greater Tampa area in 2021.

In reference to joining TOI, Dr. Raiker stated, “As an oncologist, I am always looking for ways to ensure my patients receive the best treatment possible close to their home. By joining TOI, I can bring new, innovative resources to my patients and colleagues.”

TOI is excited to bring their robust service offering to the greater Tampa area, including:

  • A leading clinical research program offering patients access to more than 100 clinical trials.
  • Comprehensive dispensary and pharmacy services to offer convenience and savings to patients receiving oral chemotherapeutics.
  • A care management program which helps patients navigate a complex healthcare system.
  • A state-of-the-art website with educational resources, scheduling capabilities, and a convenient patient portal.

TOI CEO Brad Hively shared, “Dr. Raiker is respected by his colleagues and beloved by his patients for the compassionate care he’s provided to his patients for more than 20 years. We are thrilled to be welcoming him and his team to TOI.”

About The Oncology Institute of Hope and Innovation

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is one of the largest community oncology practices in the US as well as our nation’s leading value-based oncology services platform. TOI employs 75 physicians and mid-level practitioners in 40+ clinic locations, with more than 500 total employees helping to offer leading-edge, evidence-based cancer care to a population of more than 1 million patients. TOI brings comprehensive, integrated cancer care into community settings, including clinical trials, palliative care programs, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced tertiary care settings. For more information visit www.theoncologyinstitute.com.

Contacts

Julie Korinke
Senior Manager, Marketing
562.735.3226 x.88806
juliekorinke@theoncologyinstitute.com

Contacts

Julie Korinke
Senior Manager, Marketing
562.735.3226 x.88806
juliekorinke@theoncologyinstitute.com